Article
07 May 2025
Recentive Analytics v. Fox: The Federal Circuit Provides Analysis On The Patent Eligibility Of Machine Learning Claims
AUTHORS CONTENT
Article
27 Feb 2025
Patenting AI/ML Life Sciences And TechBio Innovations – How Much Disclosure Is Sufficient?
Article
31 Jan 2025
USPTO Issues Artificial Intelligence Strategy
Article
27 Dec 2024
USPTO Takes A Hint From European Practice In Addressing Late Continuation Concerns
Article
06 Dec 2024
Overcoming Patent Challenges For AI/ML-Assisted Life Sciences (TechBio) Inventions: Strategies For Navigating Section 101 At The US Patent & Trademark Office
Article
28 Nov 2024
Best Practices In Developing Winning IP Strategies For AI Companies
Article
15 May 2024
Navigating AI Integration: USPTO's New Guidance For Patent And Trademark Practices
Article
26 Apr 2024
USPTO Issues Guidance On AI Use To Patent Professionals — AI: The Washington Report
Article
22 Nov 2021
Examining Art Units To Avoid Subject Matter Eligibility Challenges For Bioinformatics And AI-related Patents
Article
06 Sep 2021
Life Sciences Newsletter — September 2021
Article
12 Aug 2021
AI In Biotech And Synthetic Biology: What Can Be Protected? What Should Be Kept Secret?
Article
22 Oct 2020
Life Sciences Newsletter — October 2020
Article
24 Aug 2020
Life Sciences Newsletter — Inaugural Edition
Article
18 Jun 2020
Patenting Considerations For Artificial Intelligence In Biotech And Synthetic Biology – Part 2: Key Issues In Patent Subject Matter Eligibility
Article
02 Jun 2020
Patenting Considerations For Artificial Intelligence In Biotech And Synthetic Biology
Article
07 Jul 2017
Extension Of U.S. Patent And Trademark Office's Cancer Immunotherapy Pilot Program
Article
12 Jul 2016
USPTO Fast-Tracks Cancer Immunotherapy Patent Applications
Article
05 Jul 2016
Pitfalls When Refiling A Priority Application Under Article 4 Of The Paris Convention
Article
24 May 2016
UPDATE: Subject Matter Eligibility Under 35 U.S.C. § 101 – Life Sciences
Article
25 Jun 2015
Federal Circuit Invalidates Diagnostic Method Claims For Prenatal Test Under 35 U.S.C. 101